FDA 483 - Corixa Corporation - April 15, 2019

An FDA inspection of Corixa Corporation, a packager and labeler of biological drug products in Marietta, PA, revealed significant deficiencies in their packaging and labeling operations. The firm failed to adequately ensure proper labeling after finishing operations and did not maintain complete investigation records for batch failures. These observations indicate a need for improved quality control and documentation practices.